- Home
- MOLN vs NNY Comparison
MOLN vs NNY Comparison
Compare MOLN & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- NNY
- Stock Information
- Founded
- MOLN 2004
- NNY 1987
- Country
- MOLN Switzerland
- NNY United States
- Employees
- MOLN N/A
- NNY N/A
- Industry
- MOLN
- NNY Investment Managers
- Sector
- MOLN
- NNY Finance
- Exchange
- MOLN Nasdaq
- NNY Nasdaq
- Market Cap
- MOLN 183.2M
- NNY 155.1M
- IPO Year
- MOLN 2021
- NNY N/A
- Fundamental
- Price
- MOLN $3.81
- NNY $8.18
- Analyst Decision
- MOLN
- NNY
- Analyst Count
- MOLN 0
- NNY 0
- Target Price
- MOLN N/A
- NNY N/A
- AVG Volume (30 Days)
- MOLN 3.2K
- NNY 50.9K
- Earning Date
- MOLN 05-15-2025
- NNY 01-01-0001
- Dividend Yield
- MOLN N/A
- NNY 4.04%
- EPS Growth
- MOLN N/A
- NNY N/A
- EPS
- MOLN N/A
- NNY N/A
- Revenue
- MOLN $2,525,030.00
- NNY N/A
- Revenue This Year
- MOLN N/A
- NNY N/A
- Revenue Next Year
- MOLN $866.67
- NNY N/A
- P/E Ratio
- MOLN N/A
- NNY N/A
- Revenue Growth
- MOLN N/A
- NNY N/A
- 52 Week Low
- MOLN $3.36
- NNY $7.58
- 52 Week High
- MOLN $12.70
- NNY $8.87
- Technical
- Relative Strength Index (RSI)
- MOLN 46.07
- NNY 48.19
- Support Level
- MOLN $3.58
- NNY $8.09
- Resistance Level
- MOLN $4.11
- NNY $8.79
- Average True Range (ATR)
- MOLN 0.12
- NNY 0.23
- MACD
- MOLN -0.02
- NNY -0.01
- Stochastic Oscillator
- MOLN 33.74
- NNY 22.47
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.